Myoclonic epilepsy of Lafora |
Contact us |
| Return to database |
Prevalence (%) of clinical parameters based on data from 1 references describing 17 individuals
Add new symptom/sign to this disease
| Pubmed id number as a reference | Organ system affected | ||
| Number of patients in the reference | Percent affected patients (Between 0 and 1, eg. 0.1 = 10%) | ||
| Please provide your name and contact information as a reference | |||
| Name | Institute | Phone number | Email address |
List of symptoms
| Symptom/sign | Organ system | Percent affected | Pubmed id | Added on(yyyy-mm-dd) | Edit/add reference |
| Seizures | nervous | 94 % | 15781812 | 2013-04-09 | |
| Mental retardation | nervous | 82 % | 15781812 | 2013-04-09 | |
| Gait disturbances | nervous | 47 % | 15781812 | 2013-04-09 | |
| Hepatopathy | digestive | 6 % | 15781812 | 2013-04-09 |
List of references:
Lafora disease due to EPM2B mutations: a clinical and genetic study.
C Gómez-Abad, P Gómez-Garre, E Gutiérrez-Delicado, S Saygi, R Michelucci, C A Tassinari, S Rodríguez de Córdoba, J M Serratosa,
Neurology - Mar 2005